Search Results - "Bes, Cedric"

Refine Results
  1. 1

    Physicochemical and Biological Characterization of RTXM83, a New Rituximab Biosimilar by Cerutti, María L., Pesce, Analía, Bès, Cédric, Seigelchifer, Mauricio

    “…Background RTXM83 is a rituximab biosimilar with proven clinical safety and efficacy. It is the first rituximab biosimilar developed and approved in South…”
    Get full text
    Journal Article
  2. 2
  3. 3

    In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas by TROADEC, Samuel, CHENTOUF, Myriam, CIRUTTI, Martine, NGUYEN, Brigitte, OLIVE, Daniel, BES, Cedric, CHARDIS, Thierry

    Published in Journal of immunotherapy (1997) (01-02-2007)
    “…A baculovirus-expressed chimeric recombinant IgG1 (rIgG1) antibody, with Cgamma1 and Ckappa human constant domains, was derived from the murine monoclonal…”
    Get full text
    Journal Article
  4. 4

    Clinical Pharmacokinetic (PK) and Safety (Immunogenicity) of Rituximab Biosimilar RTXM83 in Combination with Chemotherapy CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) by Florez, Amalia, Di Matteo, Thiago, Fresnillo, Gloria, Tudela, Consuelo, Seigelchifer, Mauricio, Corley, Esteban, Pesce, Analia, Bes, Cedric, Millan, Susana

    Published in Blood (06-12-2014)
    “…Background: RTXM83 is a rituximab biosimilar candidate manufactured by MAbxience Company. Full spectrum of physicochemical and preclinical studies showed…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    A peptide mimetic of an anti-CD4 monoclonal antibody by rational design by Casset, Florence, Roux, Florence, Mouchet, Patrick, Bes, Cedric, Chardes, Thierry, Granier, Claude, Mani, Jean-Claude, Pugnière, Martine, Laune, Daniel, Pau, Bernard, Kaczorek, Michel, Lahana, Roger, Rees, Anthony

    “…The development of rational methods to design ‘continuous’ sequence mimetics of discontinuous regions of protein sequence has, to now, been only marginally…”
    Get full text
    Journal Article
  9. 9

    The chimeric mouse-human anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter activation by Bès, C, Cerutti, M, Briant-Longuet, L, Bresson, D, Peraldi-Roux, S, Pugnière, M, Mani, J C, Pau, B, Devaux, C, Granier, C, Devauchelle, G, Chardès, T

    Published in Human antibodies (2001)
    “…The anti-CD4 mAb 13B8.2, directed against the CDR3-like loop of the D1 domain of CD4, inhibits signal transduction pathways leading to both T cell activation…”
    Get more information
    Journal Article
  10. 10

    Pertinence of kappa and lambda recombinant antibodies directed against thyroid peroxidase in thyroid autoimmune disease by Bresson, D, Chardès, T, Chapal, N, Bès, C, Cerutti, M, Devauchelle, G, Bouanani, M, Mani, J C, Péraldi-Roux, S

    Published in Human antibodies (2001)
    “…Forty-one single-chain variable region fragments (scFvs) directed against thyroid peroxidase (TPO) were obtained by phage display libraries constructed from…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases by Chardès, Thierry, Chapal, Nicolas, Bresson, Damien, Bès, Cédric, Giudicelli, Véronique, Lefranc, Marie-Paule, Péraldi-Roux, Sylvie

    Published in Immunogenetics (New York) (01-06-2002)
    “…Human anti-thyroid peroxidase (TPO) autoantibodies (aAb) are generated during autoimmune thyroid diseases (AITD). Within recent years, increasing knowledge of…”
    Get full text
    Journal Article
  15. 15

    Application of the Spot method to the identification of peptides and amino acids from the antibody paratope that contribute to antigen binding by Laune, Daniel, Molina, Franck, Ferrières, Gaëlle, Villard, Sylvie, Bès, Cédric, Rieunier, François, Chardès, Thierry, Granier, Claude

    Published in Journal of immunological methods (01-09-2002)
    “…Overlapping peptide scans prepared by Spot synthesis have been used to map interaction sites in several systems. Here we report our experience with this…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20